153.50 USD
+0.04
0.03%
At close Dec 20, 4:00 PM EST
After hours
153.50
+0.00
0.00%
1 day
0.03%
5 days
-7.25%
1 month
-6.94%
3 months
-12.05%
6 months
-7.07%
Year to date
-6.57%
1 year
-6.64%
5 years
67.76%
10 years
925.38%
 

About: Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.

Employees: 2,900

0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

62% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 26

14% more repeat investments, than reductions

Existing positions increased: 104 | Existing positions reduced: 91

9% more capital invested

Capital invested by funds: $5.72B [Q2] → $6.25B (+$534M) [Q3]

6% more funds holding

Funds holding: 268 [Q2] → 284 (+16) [Q3]

0% more funds holding in top 10

Funds holding in top 10: 2 [Q2] → 2 (+0) [Q3]

0.32% less ownership

Funds ownership: 97.71% [Q2] → 97.39% (-0.32%) [Q3]

55% less call options, than puts

Call options by funds: $6.07M | Put options by funds: $13.5M

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$169
10%
upside
Avg. target
$169
10%
upside
High target
$169
10%
upside

1 analyst rating

positive
0%
neutral
100%
negative
0%
Baird
Robert Mason
54% 1-year accuracy
7 / 13 met price target
10%upside
$169
Neutral
Maintained
6 Nov 2024

Financial journalist opinion

Neutral
Business Wire
1 day ago
Novanta to Present at the CJS Securities 25th Annual New Ideas for the New Year Investor Conference on Tuesday, January 14, 2025
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that management will be participating at the CJS Securities 25th Annual New Ideas for the New Year Investor Conference on Tuesday, January 14, 2025, which is being held virtually. About Novanta Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equip.
Novanta to Present at the CJS Securities 25th Annual New Ideas for the New Year Investor Conference on Tuesday, January 14, 2025
Neutral
Business Wire
2 days ago
Novanta to Present at the J.P. Morgan 43rd Annual Healthcare Conference on Monday, January 13, 2025
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the J.P. Morgan 43rd Annual Healthcare Conference on Monday, January 13, 2025, in San Francisco, California. About Novanta Novanta is a leading global supplier of core technology solu.
Novanta to Present at the J.P. Morgan 43rd Annual Healthcare Conference on Monday, January 13, 2025
Neutral
Seeking Alpha
1 month ago
Novanta Inc. (NOVT) Q3 2024 Earnings Call Transcript
Novanta Inc. (NASDAQ:NOVT ) Q3 2024 Results Conference Call November 5, 2024 10:00 AM ET Company Participants Ray Nash - Corporate Finance Leader Matthijs Glastra - Chair and Chief Executive Officer Robert Buckley - Chief Financial Officer Conference Call Participants Lee Jagoda - CJS Securities Brian Drab - William Blair Rob Mason - Baird Operator Good morning. My name is Gary, and I will be your conference operator today.
Novanta Inc. (NOVT) Q3 2024 Earnings Call Transcript
Negative
Zacks Investment Research
1 month ago
Novanta (NOVT) Q3 Earnings Miss Estimates
Novanta (NOVT) came out with quarterly earnings of $0.85 per share, missing the Zacks Consensus Estimate of $0.86 per share. This compares to earnings of $0.85 per share a year ago.
Novanta (NOVT) Q3 Earnings Miss Estimates
Neutral
Business Wire
1 month ago
Novanta Announces Financial Results for the Third Quarter 2024
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the third quarter 2024. Financial Highlights Three Months Ended   (In millions, except per share amounts) September 27,     September 29,     2024     2023   GAAP           Revenue $ 244.4     $ 221.5   Operating Income $ 32.6     $ 30.3   Net Income $ 19.2     $ 21.2   Diluted EPS.
Novanta Announces Financial Results for the Third Quarter 2024
Neutral
Business Wire
2 months ago
Novanta to Present at the Baird 2024 Global Industrial Conference on Wednesday, November 13, 2024
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer is scheduled to present at the Baird 2024 Global Industrial Conference on Wednesday, November 13, 2024, in Chicago, Illinois. About Novanta Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original.
Novanta to Present at the Baird 2024 Global Industrial Conference on Wednesday, November 13, 2024
Neutral
Business Wire
2 months ago
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 5, 2024
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2024 results on Tuesday, November 5, 2024. The Company will host a conference call on Tuesday, November 5, 2024, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed onli.
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 5, 2024
Positive
Zacks Investment Research
3 months ago
4 Top Electronics Stocks With Bright Industry Prospects to Buy
The Zacks Electronics - Miscellaneous Components industry players like FN, NOVT, OSIS and AMSC are set to gain from the solid adoption of AI and the democratization of IoT techniques.
4 Top Electronics Stocks With Bright Industry Prospects to Buy
Positive
InvestorPlace
4 months ago
3 Robotics Stocks to Buy and Hold for the Potential of Huge Returns
I am fascinated by robots. From an investment standpoint, robotics looks to be the natural complement to AI's advancement.
3 Robotics Stocks to Buy and Hold for the Potential of Huge Returns
Neutral
Seeking Alpha
4 months ago
Novanta Inc. (NOVT) Q2 2024 Earnings Call Transcript
Novanta Inc. (NASDAQ:NOVT ) Q2 2024 Results Conference Call August 6, 2024 10:00 AM ET Company Participants Ray Nash - Corporate Finance Leader Matthijs Glastra - Chair & CEO Robert Buckley - CFO Conference Call Participants Lee Jagoda - CJS Securities Brian Drab - William Blair Rob Mason - Baird Operator Good morning. My name is Dorvin, and I will be your conference operator today.
Novanta Inc. (NOVT) Q2 2024 Earnings Call Transcript
Charts implemented using Lightweight Charts™